Termination of Study Sample Clauses

Termination of Study at the Institution Upon Notice. Sponsor reserves the right to terminate the Study for any reason upon thirty (30) days written notice to Institution and Investigator.
View Source
Termination of Study. The Sponsor reserves the right to discontinue this study for administrative reasons at any time. The Investigator reserves the right to discontinue the study for safety reasons at any time in collaboration with the Sponsor.
View Source
Termination of Study. After completion of the Study, Prospect shall deliver to Broker all Information including but not limited to all Notes, documents, and papers (including diskettes or other media for electronic storage of information) as they relate to any Information that is in the possession or under the control of Prospect, without making copies or summaries of any such Information, provided that in lieu of so delivering Notes prepared by Prospect, Prospect may destroy such Notes and provide Broker with a written certificate by an authorized representative of Prospect as to the fact of such destruction. Notwithstanding the foregoing, if the parties enter into a binding purchase agreement, Prospect may retain such Information. However, the retention of such Information shall be subject to the terms of the purchase agreement.
View Source
Termination of Study. If the Durham-to-Roxboro Rail Trail Planning & Feasibility Study ends prior to its completion, this Agreement will terminate, and any unexpended funds conveyed by the City and County at the time of termination shall be returned to the City and County after all consultant invoices are paid.
View Source
Termination of Study. Any PCD Program or particular Study under a PCD Program may be terminated by Isis, without cause, upon 30 days written notice.
View Source
Termination of Study. [***] the [***] the [***] with [***] to the [***]. In [***] the [***] will [***] is [***] to the [***] of the [***].
View Source
Termination of Study. This Agreement may be terminated immediately by Getinge if Getinge determines its support for the Study is inappropriate, impractical, or inadvisable to continue based on Applicable Laws and Regulations.
View Source
Termination of Study. Treatment with the investigational drug may be ended if your small cell lung cancer recurs, if the doctors treating you see side effects that they consider dangerous, if you refuse to have the treatments as recommended by your doctor or if you refuse to have the tests needed to determine whether the treatment is safe and effective, or if you become pregnant. This research study has been reviewed by INSTITUTION'S Institutional Review Board. This Board is legally responsable for making sure that research with patients is appropriate and that the patient's rights and welfare are protected. The physician in charge of this research study is ______________, telephone number _____________ If you need more information about this study before you decide to join, or at any other time, you may wish to contact him. In the event that you do decide to participate, he should also be called if there are side effects from the treatment. A non-physician whom you may call for information about the consent process, research patient's rights, or research-related injury is _______________, telephone number _________ 71/102 89 [LOGO] The SILV▇ ▇▇▇dy -------------------------------------------------------------------------------- PATIENT INFORMED CONSENT FOR CLINICAL RESEARCH Title: SURVIVAL IN AN INTERNATIONAL PHASE III PROSPECTIVE RANDOMIZED LD SMALL CELL LUNG CANCER VACCINATION STUDY WITH ADJUVANT BEC2 AND BCG Purpose: To determine whether immunization with BEC2 in combination with BCG following chemotherapy in patients with limited disease small-cell lung cancer results in longer survival than chemotherapy alone. The study will also study the "progression free survival" in the two separate treatment groups, toxicities associated with the study agents BEC2 and BCG, and the effect of these agents on the patients quality of life.
View Source

Related to Termination of Study

  • Termination of Stopped Work If a stop work order is not canceled and the work covered by such order is terminated for default or convenience, the reasonable costs resulting from the stop work order shall be allowed by adjustment or otherwise.

  • Termination of Use These terms and Your access to Our Website may be terminated by Us (at Our sole discretion) at any time without notice or any requirement to give You a reason why. In the event of termination under this clause We shall have no liability to You whatsoever (including for any consequential or direct loss You may suffer).

  • Termination of 401(k) Plan At Parent’s written request, delivered no later than fifteen (15) days prior to the Closing, the Company shall terminate the Furmanite Corporation 401(k) Savings and Investment Plan (the “Company 401(k) Plan”) effective immediately prior to the Closing Date and contingent upon the occurrence of the Closing, and upon such termination, shall cease all further contributions to the Company 401(k) Plan for pay periods beginning on and after the Closing Date and, to the extent the Company 401(k) Plan provides for loans to participants, and upon such termination, shall cease making any such additional loans effective immediately prior to the Closing Date. If Parent does not instruct the Company to terminate the Company 401(k) Plan, nothing herein shall be deemed to prevent the Surviving Corporation or Parent from terminating the Company 401(k) Plan following the Closing in accordance with applicable Law. In the event that Parent instructs the Company to terminate the Company 401(k) Plan, (a) prior to the Closing Date and thereafter (as applicable), the Company and Parent shall take any and all action as may be required, including amendments to the Company 401(k) Plan and/or the corresponding 401(k) plan sponsored or maintained by Parent or one of its Subsidiaries (the “Parent 401(k) Plan”) to comply with applicable Law, (b) subject to the receipt of a favorable IRS determination letter with respect to the termination of the Company 401(k) Plan, to permit each employee of the Company and its Subsidiaries who continues to be employed by Parent or its Subsidiaries (including, for the avoidance of doubt the Surviving Corporation and its Subsidiaries) immediately following the Effective Time (each, a “Continuing Employee”) to make rollover contributions of “eligible rollover distributions” (within the meaning of Section 401(a)(31) of the Code, including of loans) in cash or notes (in the case of loans) in an amount equal to the eligible rollover distribution portion of the account balance distributable to such Continuing Employee from the Company 401(k) Plan to the corresponding Parent 401(k) Plan, and (c) upon any termination of the Company 401(k) Plan in accordance with this Section 6.03, the Continuing Employees shall be eligible to participate, effective as of the Effective Time, in the Parent 401(k) Plan.

  • Termination of Review If a Review is in process and the Notes will be paid in full on the next Payment Date, the Servicer will notify the Asset Representations Reviewer and the Indenture Trustee no less than ten days before that Payment Date. On receipt of notice, the Asset Representations Reviewer will terminate the Review immediately and will not be obligated to deliver a Review Report.

  • Termination of Agreement If this Agreement is terminated by the Representatives in accordance with the provisions of Section 5 or Section 9(a)(i) hereof, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters.